Ovintiv Inc.'s SEC filings document the formal disclosure record for its oil, NGL and natural gas exploration and production operations in the United States and Canada. Form 8-K reports cover operating and financial results, dividend declarations, completed asset dispositions, acquisition-related financial statements and pro forma information, credit agreement activity, note redemption matters and Regulation FD exhibits.
Proxy and annual-meeting filings describe director elections, board committee assignments, advisory votes on executive compensation, auditor ratification and other shareholder voting matters. The filings also identify the company's common stock registration, capital-structure disclosures, material agreements and risk-factor discussions related to its E&P portfolio and financing activities.
Ovintiv Inc. reported an insider stock transaction by its President & CEO, who is also a director. On 12/04/2025, the executive exercised stock appreciation rights to acquire 10,373 shares of Ovintiv common stock at an exercise price of $35.80 per share. These rights were originally granted on 03/08/2019 and were scheduled to expire on 03/08/2026, and the exercise reduced the remaining balance of these derivative awards to zero.
On the same date, the executive sold 10,323 Ovintiv common shares at a price of $42.32 per share. After these transactions, the executive directly held 234,689 shares of Ovintiv common stock. Each stock appreciation right represented the economic equivalent of one share of Ovintiv common stock.
Ovintiv Inc. entered into a new Two-Year Term Credit Agreement providing a term loan facility of up to $1.2 billion. The facility will be funded once certain conditions are met, including the substantially concurrent closing of Ovintiv Canada ULC’s acquisition of all NuVista Energy Ltd. common shares it does not already own. Ovintiv guarantees Ovintiv Canada’s obligations under the agreement.
The term loan will mature on the second anniversary of the funding date and will bear interest at either a base or Canadian prime rate plus an applicable margin of 0–100 basis points, or at Term SOFR or Adjusted Term CORRA plus 100–200 basis points, in each case depending on Ovintiv’s credit ratings. The agreement includes covenants typical for this type of facility, including a requirement that Ovintiv’s consolidated debt-to-capitalization ratio not exceed 60% at each quarter-end, as well as customary events of default that could allow lenders holding more than 50% of commitments or outstanding loans to terminate commitments and demand immediate repayment.
Ovintiv Inc. (OVV) executive vice president of Corporate Services reported a routine stock transaction. On 11/19/2025, the officer exercised 6,427 stock options for Ovintiv common shares at an exercise price of $33.98 per share, then sold 6,427 common shares on the same date at a price of $38.92 per share. After these transactions, the reporting person directly owned 70,163 Ovintiv common shares. The option award and sale prices were originally denominated in Canadian dollars and converted to U.S. dollars using the Bank of Canada exchange rate on the transaction date.
Ovintiv Inc. (OVV) disclosed a director’s equity award on a Form 4. On 11/10/2025, the reporting person acquired 611 Deferred Share Units (DSUs) at a stated price of $0, bringing derivative holdings to 6,329 DSUs, held in direct ownership.
Each DSU is the economic equivalent of one share of common stock, accrues dividend-equivalent DSUs, and is held until retirement from the Board.
Ovintiv Inc. (OVV) director reported an equity award on a Form 4. On 11/10/2025, the reporting person acquired 606 Deferred Share Units (DSUs) at $0. Following this transaction, the person beneficially owns 1,846 derivative securities.
Each DSU is economically equivalent to one share of Ovintiv common stock and accrues dividend-equivalent DSUs. The filing notes DSUs are held until retirement from the Board. Ownership is reported as Direct (D).
Ovintiv Inc. (OVV) reported a director’s equity transaction on Form 4. On November 10, 2025, the reporting person acquired 740 Deferred Share Units (DSUs) at a reported price of $0, reflecting a board equity award rather than an open‑market purchase. Following this grant, the reporting person beneficially owns 10,621 derivative securities, held directly.
Each DSU is the economic equivalent of one share of Ovintiv common stock, accrues dividend‑equivalent DSUs, and is held until the individual retires from the Board.
Ovintiv Inc. (OVV) agreed to acquire NuVista Energy in a stock-and-cash deal structured under an Alberta court-approved arrangement. Each NuVista share may be exchanged for C$18.00 in cash, 0.344 OVV share, or a mix, subject to proration capped at C$1,568,577,429 in cash and 29,977,258 OVV shares. On a fully pro‑rated basis, consideration equals about C$9.00 in cash plus 0.172 OVV share per NuVista share.
Closing requires NuVista shareholder approval of at least 66 2/3%, approval by the Court of King’s Bench of Alberta, NYSE and TSX listing authorization for the new OVV shares, and approvals under the Competition Act (Canada) and the Investment Canada Act. The arrangement has an outside date of May 4, 2026, extendable three months if regulatory approvals remain outstanding. A C$130 million termination fee is payable by either side in specified circumstances. The OVV shares to be issued will rely on the Section 3(a)(10) Securities Act exemption following a court fairness hearing.
FMR LLC filed an amended Schedule 13G/A reporting beneficial ownership of 20,798,631.92 shares of Ovintiv Inc. common stock, or 8.1% of the class, as of 09/30/2025. The filing also lists Abigail P. Johnson as a reporting person.
FMR reports sole voting power over 20,071,470.20 shares and sole dispositive power over 20,798,631.92 shares, with no shared voting or dispositive power. The certification states the securities were acquired and are held in the ordinary course and not for the purpose of changing or influencing control.
The filing notes that one or more other persons may have rights to dividends or sale proceeds tied to these shares, and no single other person’s interest exceeds five percent of the outstanding common stock.
Ovintiv Inc. reported Q3 2025 results. Total revenues were $2,066 million versus $2,324 million a year ago. Operating income was $273 million versus $527 million. Net earnings were $148 million (diluted EPS $0.57) versus $507 million ($1.92).
For the first nine months, total revenues were $6,761 million versus $6,964 million, with net earnings of $296 million (diluted EPS $1.13) versus $1,185 million. Q3 included $141 million of impairments recorded in Canadian Operations; year‑to‑date impairments totaled $871 million. USA Operations delivered Q3 operating income of $398 million versus $501 million, while Canadian Operations posted a Q3 operating loss of $35 million versus income of $60 million.
Cash from operating activities was $812 million in Q3 and $2,698 million year‑to‑date. Year‑to‑date capital expenditures were $1,682 million; acquisitions used $2,282 million and divestitures provided $1,922 million. The company repurchased $307 million of common shares and paid $232 million in dividends year‑to‑date, including a Q3 dividend of $0.30 per share. Long‑term debt was $4,393 million (current portion $819 million). Shares outstanding were 253.3 million as of September 30, 2025. Ovintiv also reclassified its Market Optimization activities into USA and Canadian segments.
Ovintiv Inc. (OVV) furnished an update on its third‑quarter performance, announcing that it issued a news release with financial and operating results for the quarter ended September 30, 2025, alongside selected and supplemental financial information.
The Board declared a quarterly dividend of $0.30 per share, payable on December 31, 2025 to shareholders of record as of December 15, 2025. The company furnished a news release and supplemental materials as Exhibits 99.1 and 99.2; these materials are furnished under the Exchange Act and not deemed filed.